Dyronib 20mg Tablet

About

Dyronib 20mg Tablet is a potent oral tyrosine kinase inhibitor designed to selectively target specific enzymes involved in cancer cell growth and proliferation. By inhibiting these aberrant kinase activities, Dyronib disrupts critical signaling pathways that drive tumor development, leading to reduced cell division and increased apoptosis in malignant cells. It is typically prescribed for the treatment of certain types of cancer, particularly those characterized by specific genetic mutations or overexpression of target kinases. The precise mechanism of action allows for a more targeted approach to therapy, aiming to minimize damage to healthy cells while effectively controlling disease progression. Regular monitoring of patient response and potential side effects is essential throughout the treatment course.

Uses

• Treatment of chronic myeloid leukemia (CML).
• Management of gastrointestinal stromal tumors (GIST).
• Therapy for certain types of advanced renal cell carcinoma.
• Treatment of specific solid tumors with kinase mutations.

Directions For Use

Take orally with food, exactly as prescribed by your doctor. Do not crush or chew the tablet.

Benefits

• Targets specific cancer pathways.
• Inhibits tumor growth and progression.
• May improve progression-free survival.
• Offers a targeted therapy approach.
• Available in convenient oral form.
• Can lead to disease remission in some cases.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Rash
• Fluid retention (edema)
• Muscle cramps
• Headache
• Abdominal pain
• Myelosuppression (low blood counts)
• Liver enzyme elevation
• Cardiac dysfunction (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver toxicity and exacerbate side effects.
• Pregnancy - Contraindicated during pregnancy due to potential fetal harm; effective contraception is required for women of childbearing potential.
• Breastfeeding - Not recommended during breastfeeding as the drug may pass into breast milk and harm the infant.
• Liver - Use with extreme caution in patients with hepatic impairment; dose adjustments and frequent liver function monitoring are necessary.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be required based on kidney function.
• Lung - Monitor for pulmonary toxicity, including interstitial lung disease, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.